Johnson & Johnson Heading Back to Court

Representatives of Johnson & Johnson and the state of Texas will head back to court on Tuesday over a $158 million settlement agreement announced in January involving the drug Risperdal, a spokesman for Texas Attorney General Greg Abbott said on Sunday. "As far as we knew, we had a solid settlement," said Tom Kelley, Abbott's spokesman. "We'll have more information on Tuesday about what has caused (Johnson & Johnson) some concerns." A spokeswoman for Johnson & Johnson declined to comment a bout the hearing before state District Judge John Dietz in Austin.

Back to news